PHAR6213
Molecular Pathogenesis
10 Units
Available in 2013
| Callaghan Campus | Trimester 1 |
|---|
Previously offered in 2012, 2011, 2010, 2009
Introduces students to the molecular basis of disease and drug response. As knowledge of the genetic basis of disease increases so does the opportunities for drug targeting and patient specific-treatments. This course considers the two key elements - the genetics of disease and the genetics of drug response (pharmacogenomics).
| Objectives | Students should: 1. Have a fundamental understanding of the molecular basis of disease; 2. Understand the molecular determinants of drug response; 3. Understand the molecular basis of cancer therapeutics; 4. Understand the impact of biotherapy on therapeutics, pharmaceutical industry and society; and 5. Gain basic understanding of the ethical issues related to the use of biotherapy. |
||||||
|---|---|---|---|---|---|---|---|
| Content | 1. Drug targets 2. Genomics 3. Proteomics 4. Pharmacogenetics 5. Pharmacogenomics 6. Monoclonal antibody therapeutics 7. Peptide-based therapeutics 8. Nucleic Acid therapeutics including anti-sense and gene-therapy 9. Cell-based therapeutics 10.SNP analysis 11.Ethical issues arising from the use of biotherapeutics |
||||||
| Replacing Course(s) | Replaces PHAR6017 Molecular Pathogenesis 10 Units. | ||||||
| Transition | N/A | ||||||
| Industrial Experience | 0 | ||||||
| Assumed Knowledge | PHAR6123 Human Genomics and Biomolecular Analysis for Pharmacy. | ||||||
| Modes of Delivery | Internal Mode | ||||||
| Teaching Methods | Problem Based Learning
Lecture Tutorial |
||||||
| Assessment Items |
|
||||||
| Contact Hours | Lecture: for 3 hour(s) per Week for 10 weeks Tutorial: for 2 hour(s) per Week for 10 weeks Lecture: for 1 hour(s) per Week for 1 weeks |
||||||
| Compulsory Components |
|
||||||
| Timetables | 2013 Course Timetables for PHAR6213 |